Q1 2023 Holdings
Filed 2023-05-15 | 58 holdings | $338.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $10.9M | 164,620 | 3.2% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $11.8M | 110,000 | 3.5% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $13.9M | 225,000 | 4.1% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $13.9M | 475,000 | 4.1% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $16.5M | 1,100,000 | 4.9% |
| Sarepta Therapeutics Inc(SRPT)Call | COM | 803607100 | $17.2M | 125,000 | 5.1% |
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $22.9M | 300,000 | 6.8% |
| Reata Pharmaceuticals Inc(RETAEUR)Call | CL A | 75615P103 | $27.3M | 300,000 | 8.1% |